Binimetinib (Mektovi,Mektodx)

Binimetinib is a targeted anti-cancer drug that works by blocking the MEK protein (a key protein that stimulates cancer cell growth) within cancer cells, thereby inhibiting tumor growth.

15mg*84tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Binimetinib Medication Guide

Binimetinib (Mektovi) Uses, Dosage, Side Effects & Patient Tips

In June 2018, the U.S. Food and Drug Administration (FDA) approved binimetinib for marketing as a treatment for unresectable metastatic melanoma or me···【More】
Update: 05 Mar,2026Source: BigbearViews: 95
Binimetinib (Mektovi) Patient Guide: Uses, Dosage, and What to Expect

Binimetinib, developed by Pierre Fabre in France, was approved by the U.S. Food and Drug Administration (FDA) in 2018, providing a new treatment optio···【More】
Update: 04 Mar,2026Source: BigbearViews: 92
Binimetinib Dosage and Administration: Common Dosage and Dosage Adjustment

Binimetinib is often used in combination with encorafenib. These two drugs target the same signaling pathway at different points and can synergistical···【More】
Update: 04 Mar,2026Source: BigbearViews: 87
Side effects and adverse reactions of Binimetinib

While binimetinib offers a new treatment option for melanoma patients, its potential adverse reactions still require careful monitoring during use.Sid···【More】
Update: 04 Mar,2026Source: BigbearViews: 88